Strategies to prevent relapse after stem cell transplantation

Bart Scott, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, talks on the strategies used to minimize the risk of relapse in patients with hematological malignancies undergoing stem cell transplantation. Whilst increasing the intensity of conditioning regimens has proven to reduce relapse risk, it is also associated with an increased toxicity. Dr Scott outlines several ongoing clinical trials exploring novel conditioning regimens which are less toxic. This interview took place at the 2021 Relapse After HSCT² Workshop in New York, NY.